E-LIB Suche - Ergebnisse für: Clar, Kim

1

Phase I/II trial of a peptide-based COVID-19 T-cell activat..:

Heitmann, Jonas S. ; Tandler, Claudia ; Marconato, Maddalena...
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

2

Controversial Role of the Immune Checkpoint OX40L Expressio..:

Rittig, Susanne M. ; Lutz, Martina S. ; Clar, Kim L....
Frontiers in Oncology. 12 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

3

Platelet-expressed immune checkpoint regulator GITRL in bre..:

Zhou, Yanjun ; Heitmann, Jonas S. ; Clar, Kim L....
Cancer Immunology, Immunotherapy. 70 (2021) 9 - p. 2483-2496 , 2021

Link: https://doi.org/10.1007/..

4

Bispecific NKG2D-CD3 and NKG2D-CD16 Fusion Proteins as Nove..:

Hagelstein, Ilona ; Lutz, Martina S. ; Schmidt, Moritz...
Frontiers in Immunology. 12 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

5

Receptor Activator of NF-κB (RANK) Confers Resistance to Ch..:

Clar, Kim ; Weber, Lisa ; Schmied, Bastian...
Cancers. 13 (2021) 23 - p. 6122 , 2021

Link: https://doi.org/10.3390/..

6

Inhibition of NK Reactivity Against Solid Tumors by Platele..:

Clar, Kim ; Hinterleitner, Clemens ; Schneider, Pascal..
Cancers. 11 (2019) 3 - p. 277 , 2019

Link: https://doi.org/10.3390/..

7

Cancer Cells Invade Confined Microchannels via a Self-Direc..:

Holle, Andrew W. ; Govindan Kutty Devi, Neethu ; Clar, Kim...
Nano Letters. 19 (2019) 4 - p. 2280-2290 , 2019

Link: https://doi.org/10.1021/..

8

The novel deubiquitinase inhibitor b-AP15 induces direct an..:

Kropp, Korbinian N. ; Maurer, Stefanie ; Rothfelder, Kathrin...
Cancer Immunology, Immunotherapy. 67 (2018) 6 - p. 935-947 , 2018

Link: https://doi.org/10.1007/..

9

Phase I/II trial of a peptide-based COVID-19 T-cell activat..:

Heitmann, Jonas S ; Tandler, Claudia ; Marconato, Maddalena...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439231/. , 2023

Link: http://www.ncbi.nlm.nih...

10

Controversial Role of the Immune Checkpoint OX40L Expressio..:

Rittig, Susanne M ; Lutz, Martina S ; Clar, Kim L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304936/. , 2022

Link: http://www.ncbi.nlm.nih...

11

Platelet-expressed immune checkpoint regulator GITRL in bre..:

Zhou, Yanjun ; Heitmann, Jonas S ; Clar, Kim L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360840/. , 2021

Link: http://www.ncbi.nlm.nih...

12

Platelet-expressed immune checkpoint regulator GITRL in bre..:

Zhou, Yanjun ; Heitmann, Jonas S ; Clar, Kim...
https://repository.publisso.de/resource/frl:6451433. , 2021

Link: https://repository.publi..

13

Bispecific NKG2D-CD3 and NKG2D-CD16 Fusion Proteins as Nove..:

Hagelstein, Ilona ; Lutz, Martina S ; Schmidt, Moritz...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079770/. , 2021

Link: http://www.ncbi.nlm.nih...

14

Receptor Activator of NF-κB (RANK) Confers Resistance to Ch..:

Clar, Kim L ; Weber, Lisa M ; Schmied, Bastian J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657109/. , 2021

Link: http://www.ncbi.nlm.nih...

15

Inhibition of NK Reactivity Against Solid Tumors by Platele..:

Clar, Kim L ; Hinterleitner, Clemens ; Schneider, Pascal..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468810/. , 2019

Link: http://www.ncbi.nlm.nih...